Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Ocera Therapeutics patents

List of Ocera Therapeutics patents

List of Korg patents

List of HYPRES patents

List of Pason patents

Hybrid cloud computing venture capital investors

List of funding rounds for CometChat

Patents where

Current Assignee

Name

is

Ocera Therapeutics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9604909 L-ornithine phenyl acetate and methods of making thereof	Patent 9604909 was granted and assigned to Ocera Therapeutics on March, 2017 by the United States Patent and Trademark Office.	Ocera Therapeutics	Ocera Therapeutics		United States Patent and Trademark Office	9604909	March 28, 2017
	‌ US Patent 9260379 Methods of making L-ornithine phenyl acetate	Patent 9260379 was granted and assigned to Ocera Therapeutics on February, 2016 by the United States Patent and Trademark Office.	Ocera Therapeutics	Ocera Therapeutics		United States Patent and Trademark Office	9260379	February 16, 2016
	‌ US Patent 8946473 Methods of making L-ornithine phenyl acetate	Patent 8946473 was granted and assigned to Ocera Therapeutics on February, 2015 by the United States Patent and Trademark Office.		Ocera Therapeutics		United States Patent and Trademark Office	8946473	February 3, 2015
	‌ US Patent 9034925 L-ornithine phenyl acetate and methods of making thereof	Patent 9034925 was granted and assigned to Ocera Therapeutics on May, 2015 by the United States Patent and Trademark Office.	Ocera Therapeutics	Ocera Therapeutics		United States Patent and Trademark Office	9034925	May 19, 2015
	‌ US Patent 9371297 Macrocyclic ghrelin receptor modulators and methods of using the same	Patent 9371297 was granted and assigned to Ocera Therapeutics on June, 2016 by the United States Patent and Trademark Office.		Ocera Therapeutics		United States Patent and Trademark Office	9371297	June 21, 2016
	‌ US Patent 10040751 Intermediates for macrocyclic compounds	Patent 10040751 was granted and assigned to Ocera Therapeutics on August, 2018 by the United States Patent and Trademark Office.	Ocera Therapeutics	Ocera Therapeutics		United States Patent and Trademark Office	10040751	August 7, 2018
	‌ US Patent 9409945 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery	Patent 9409945 was granted and assigned to Ocera Therapeutics on August, 2016 by the United States Patent and Trademark Office.	Ocera Therapeutics	Ocera Therapeutics		United States Patent and Trademark Office	9409945	August 9, 2016
	‌ US Patent 11161802 L-ornithine phenyl acetate and methods of making thereof	Patent 11161802 was granted and assigned to Ocera Therapeutics on November, 2021 by the United States Patent and Trademark Office.	Ocera Therapeutics	Ocera Therapeutics		United States Patent and Trademark Office	11161802	November 2, 2021
	‌ US Patent 10258602 Macrocyclic ghrelin receptor modulators and methods of using the same	Patent 10258602 was granted and assigned to Ocera Therapeutics on April, 2019 by the United States Patent and Trademark Office.	Ocera Therapeutics	Ocera Therapeutics		United States Patent and Trademark Office	10258602	April 16, 2019
	‌ US Patent 9018419 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery	Patent 9018419 was granted and assigned to Ocera Therapeutics on April, 2015 by the United States Patent and Trademark Office.		Ocera Therapeutics		United States Patent and Trademark Office	9018419	April 28, 2015
	‌ US Patent 9493505 Macrocyclic modulators of the ghrelin receptor	Patent 9493505 was granted and assigned to Ocera Therapeutics on November, 2016 by the United States Patent and Trademark Office.	Ocera Therapeutics	Ocera Therapeutics		United States Patent and Trademark Office	9493505	November 15, 2016
	‌ US Patent 9133235 Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders	Patent 9133235 was granted and assigned to Ocera Therapeutics on September, 2015 by the United States Patent and Trademark Office.		Ocera Therapeutics		United States Patent and Trademark Office	9133235	September 15, 2015
	‌ US Patent 9949949 Macrocyclic ghrelin receptor modulators and methods of using the same	Patent 9949949 was granted and assigned to Ocera Therapeutics on April, 2018 by the United States Patent and Trademark Office.	Ocera Therapeutics	Ocera Therapeutics		United States Patent and Trademark Office	9949949	April 24, 2018
	‌ US Patent 9181298 Intermediates for macrocyclic compounds	Patent 9181298 was granted and assigned to Ocera Therapeutics on November, 2015 by the United States Patent and Trademark Office.		Ocera Therapeutics		United States Patent and Trademark Office	9181298	November 10, 2015
	‌ US Patent 8921521 Macrocyclic modulators of the Ghrelin receptor			Ocera Therapeutics		United States Patent and Trademark Office	8921521	December 30, 2014

15 results

0 selected

15 results

0 selected